Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD

NCT02812862 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Rationale obsolete

Conditions

COPD

Interventions

DRUG: Spiolto® Respimat® (Tiotropium / Olodaterol)

Sponsor

RWTH Aachen University